InSysBio announces its participation in the PAGE Meeting 2026 which is to be held from June 2-5, 2026 in Dubrovnik, Croatia. InSysBio team is going to present its QSP modeling services & software to optimize drug development at Booth #22 and posters, namely:

Poster Session II, Wednesday, June 3, 15:20 PM–16:50 PM:

• II-035 "Quantitative Systems Pharmacology Modeling to Explore Alternative Step-Up Dosing Regimens for Tarlatamab, a DLL3-Targeting T-Cell Engager" by Dmitry Shchelokov, Oleg Demin Jr, Galina Saynukova

Software Demonstration:

• S-07 "CYTOCON and fIVE DB: Freely Accessible Databases for Streamlining QSP Model Calibration and Validation" by Vladislav Leonov, Anna Kopeykina, Almina Polinova, Violetta Polinova, Elita Gerasimuk, Nikolay Pervushin, Nail Gizzatkulov, Ekaterina Mogilevskaya, Ekaterina Goryacheva, Oleg Demin

Check out our posters and Booth #22!

About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio's cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

Share